A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity
Non-steroidal anti-inflammatory drugs (NSAIDs) represent a diverse class
of drugs and are among the most commonly used analgesics for arthritic
pain worldwide, though long-term use is associated with a spectrum of
adverse effects. The introduction of cyclooxygenase-2-selective NSAIDs
early in the last decade offered an alternative to traditional NSAIDs
with similar efficacy and improved gastrointestinal tolerability;
however, emerging concerns about cardiovascular safety resulted in the
withdrawal of two agents (rofecoxib and valdecoxib) in the mid-2000s
and, subsequently, in an overall reduction in NSAID use. It is now
understood that all NSAIDs are associated with some varying degree of
gastrointestinal and cardiovascular risk. Guidelines still recommend
their use, but little is known of how patients use these agents. While
strategies and guidelines aimed at reducing NSAID-associated
complications exist, there is a need for evidence-based algorithms
combining cardiovascular and gastrointestinal factors that can be used
to aid treatment decisions at an individual patient level.
http://www.docguide.com/turbulent-decade-nsaids-update-current-concepts-classification-epidemiology-comparative-efficacy-and?tsid=6#comments
http://www.docguide.com/turbulent-decade-nsaids-update-current-concepts-classification-epidemiology-comparative-efficacy-and?tsid=6#comments
Commentaires
Enregistrer un commentaire